| Financial Year |
March 31 2023 |
| Monetary Funds |
792,728,125.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
109,280,992.77 |
| Advances to Suppliers |
3,268,488.99 |
| Other Receivables |
1,645,184.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
614,203.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,746,346.06 |
| Total Current Assets |
909,283,341.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
49,731,984.49 |
| Under-construction Projects |
23,247,068.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,793,932,215.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,665,469.97 |
| Other Non-Current Assets |
16,000,000.00 |
| Sub-Total of Non-Current Assets |
11,892,576,738.18 |
| Total Assets |
12,801,860,079.48 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
276,975,804.02 |
| Accounts Received In Advance |
6,745,848.63 |
| Employee Compensation Payable |
13,761,579.67 |
| Taxes Payable |
56,466,987.20 |
| Interest Payable |
24,365,618.51 |
| Dividend Payable |
79,060,853.43 |
| Other payables |
696,222,988.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
303,888,888.88 |
| Other Current Liabilities |
740,987.39 |
| Sub-Total of Current Liabilities |
1,354,830,244.80 |
| Long-term Loans |
6,647,770,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
128,538,001.79 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,778,634,135.97 |
| Total Liabilities |
8,133,464,380.77 |
| Paid-In Capital(Or Share Stock) |
1,467,310,196.00 |
| Capital Surplus |
2,793,310,451.59 |
| Surplus Reserve |
278,746,445.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
129,028,605.54 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,668,395,698.71 |
| Owner's Equity（Stockholder's Equity） |
4,668,395,698.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,801,860,079.48 |
